| |
| |
|
| Insider
Information: |
Coles N Anthony |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
9 |
|
| Direct
Shares |
1,005,229 |
|
|
Indirect Shares
|
124,745 |
|
|
| Direct
Value |
$35,743,220 |
|
|
|
Indirect Value
|
$4,837,318 |
|
|
| Total
Shares |
1,129,974 |
|
|
| Total
Value |
$40,580,538 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 1.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
SVP, Comm. Ops. |
2005-02-03 |
74,540 |
2005-02-03 |
2,076 |
Premium* |
|
|
NPS Pharmaceuticals Inc |
NPSP |
President, COO & Direc... |
2008-03-17 |
220,066 |
2007-01-31 |
0 |
Premium* |
|
|
Onyx Pharmaceuticals Inc |
ONXX |
Chairman & CEO, Director |
2013-10-01 |
0 |
2008-03-31 |
0 |
Premium* |
|
|
Laboratory Corp of America |
LH |
Director |
2013-02-15 |
2,584 |
2011-01-03 |
0 |
Premium* |
|
|
Crispr Therapeutics Ag |
CRSP |
Director |
2016-10-24 |
0 |
2016-10-24 |
70,000 |
Premium* |
|
|
McKesson Corp |
MCK |
Director |
2020-08-17 |
0 |
2018-07-25 |
0 |
Premium* |
|
|
Regeneron Pharmaceuticals Inc |
REGN |
Director |
2024-01-02 |
1,393 |
2019-01-02 |
0 |
Premium* |
|
|
Kineta Ord Shs |
KA |
Executive Chair, Direc... |
2021-02-01 |
691,008 |
2021-02-01 |
52,669 |
Premium* |
|
|
Cerevel Therapeutics Holdings, I... |
CERE |
|
2024-05-10 |
15,638 |
2022-12-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
115 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Comm. Ops. |
• – – |
2003-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,920 |
1,920 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Comm. Ops. |
• – – |
2004-03-17 |
4 |
A |
$0.01 |
$19 |
D/D |
1,920 |
3,840 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Comm. Ops. |
• – – |
2004-05-06 |
4 |
A |
$0.01 |
$650 |
D/D |
65,000 |
68,840 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP, Comm. Ops. |
• – – |
2005-02-03 |
4 |
A |
$0.01 |
$57 |
D/D |
5,700 |
74,540 |
|
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
CEO, President and Director |
• • – |
2007-01-31 |
4 |
A |
$3.22 |
$25,052 |
D/D |
7,780 |
7,780 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, COO & Director |
• • – |
2007-11-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
45,000 |
52,780 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, COO & Director |
• • – |
2008-01-11 |
4 |
D |
$3.87 |
$35,999 |
D/D |
(9,302) |
69,317 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, COO & Director |
• • – |
2008-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
25,839 |
78,619 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, COO & Director |
• • – |
2008-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
76,336 |
147,638 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, COO & Director |
• • – |
2008-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
135,000 |
282,638 |
0 |
- |
|
| NPSP |
NPS Pharmaceuticals Inc |
President, COO & Director |
• • – |
2008-03-17 |
4 |
D |
$3.85 |
$240,902 |
D/D |
(62,572) |
220,066 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2008-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
60,000 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2009-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
88,891 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2009-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
75,000 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2009-04-01 |
4 |
AS |
$27.55 |
$170,402 |
D/D |
(6,109) |
68,891 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2009-04-06 |
4 |
AS |
$27.31 |
$204,825 |
D/D |
(7,500) |
81,391 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2009-04-09 |
5 |
AS |
$30.00 |
$317,640 |
D/D |
(10,588) |
70,803 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2009-04-09 |
5/A |
AS |
$30.00 |
$316,740 |
D/D |
(10,558) |
70,833 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2010-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
21,000 |
93,064 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2010-04-01 |
4 |
AS |
$30.10 |
$268,554 |
D/D |
(8,922) |
84,142 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2010-04-20 |
4 |
AS |
$29.94 |
$47,201 |
D/D |
(1,576) |
82,566 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2010-08-17 |
4 |
S |
$26.96 |
$198,830 |
D/D |
(7,375) |
75,927 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2010-08-19 |
4 |
S |
$26.08 |
$329,211 |
D/D |
(12,625) |
63,302 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
President & CEO |
• • – |
2010-12-07 |
4 |
AS |
$32.00 |
$437,408 |
D/D |
(13,669) |
49,633 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
Director |
– • – |
2011-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
300 |
300 |
0 |
- |
|
115 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
